Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Anthrax 2019 NIAID 5R01AI097167-06 Nutrient Uptake during Anthrax Disease MARESSO, ANTHONY BAYLOR COLLEGE OF MEDICINE TX $396,250
Anthrax 2019 NIAID 5R01AI033537-24 Virulence gene expression by Bacillus anthracis KOEHLER, THERESA UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON TX $346,500
Anthrax 2019 NIGMS 5R01GM062357-17 Riboswitch mechanism unraveled at the single molecule level WALTER, NILS UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $377,589
Anthrax 2019 NIAID 5R21AI131037-02 Development of a Multivalent Biodefense Vaccine KLOSE, KARL UNIVERSITY OF TEXAS SAN ANTONIO TX $223,250
Anthrax 2019 NIAID 5R01AI073843-11 Pathobiology of heme inducible transporters in Gram positive pathogens SKAAR, ERIC VANDERBILT UNIVERSITY MEDICAL CENTER TN $394,304
Anthrax 2019 NIAID 5R44AI118000-04 Preclinical development of teixobactin, a new antibiotic HUGHES, DALLAS NOVOBIOTIC PHARMACEUTICALS, LLC MA $996,881
Anthrax 2019 NIAID 5U19AI117892-05 8838 B Cell Population Dynamics in Affinity Maturation KELSOE, GARNETT DUKE UNIVERSITY NC $538,503
Anthrax 2019 NIAID 5U19AI117892-05 8839 Structures and Interactions of Antibodies Produced by Affinity Maturation HARRISON, STEPHEN BOSTON CHILDREN'S HOSPITAL MA $351,043
Anthrax 2019 NIAID 2U19AI062629-16 7833 Administrative Core COGGESHALL, KENNETH OKLAHOMA MEDICAL RESEARCH FOUNDATION OK $157,320
Anthrax 2019 NIAID 2U19AI062629-16 7835 Flow Cytometry Core THOMPSON, LINDA OKLAHOMA MEDICAL RESEARCH FOUNDATION OK $83,904
Anthrax 2019 NIAID 2U19AI062629-16 7836 Animal Model Core LUPU, FLOREA OKLAHOMA MEDICAL RESEARCH FOUNDATION OK $610,443
Anthrax 2019 NIAID 2U19AI062629-16 7837 Immune cell mechanisms of Bacillus anthracis sepsis FARRIS, A OKLAHOMA MEDICAL RESEARCH FOUNDATION OK $480,700
Anthrax 2019 NIAID 2U19AI062629-16 7838 Complement and coagulation in B. anthracis peptidoglycan-induced sepsis COGGESHALL, KENNETH OKLAHOMA MEDICAL RESEARCH FOUNDATION OK $454,480
Anthrax 2019 NIAID 2U19AI062629-16 7839 Mechanisms of Humoral Immune Protection Induced by Anthrax Vaccine Adsorbed JAMES, JUDITH OKLAHOMA MEDICAL RESEARCH FOUNDATION OK $480,349
Anthrax 2019 NIAID 1F31AI140050-01A1 Host-pathogen interactions drive regulatory evolution of the anthrax toxin receptor CHOATE, LAUREN CORNELL UNIVERSITY NY $41,496
Anthrax 2019 NIAID 5R01AI069227-13 Surface Proteins of Bacillus anthracis MISSIAKAS, DOMINIQUE UNIVERSITY OF CHICAGO IL $405,000
Anthrax 2019 RMAP 5U01GM125289-03 Development of novel approaches for stereoselective construction of glycosidic linkages ZHANG, LIMING UNIVERSITY OF CALIFORNIA SANTA BARBARA CA $614,888
Anthrax 2019 NIEHS 5R35ES028303-03 Mechanism of Eukaryotic Environmental Mutagenesis WALKER, GRAHAM MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $532,583
Anthrax 2019 NIAID 5R01AI127658-05 Novel vita-vaccine formula combines safety of dead and efficacy of live vaccines BLANDER, JULIE WEILL MEDICAL COLL OF CORNELL UNIV NY $419,267
Anthrax 2019 NIAID 1R03AI142361-01A1 CryoEM Structures of LF-Anthrax pore translocon at pH 5.5 FREUDENTHAL, BRET UNIVERSITY OF KANSAS MEDICAL CENTER KS $76,500
Anthrax 2019 NIAID 2R44AI136137-02A1 Preclinical development of Novo29, a new antibiotic LING, LOSEE NOVOBIOTIC PHARMACEUTICALS, LLC MA $999,992
Anthrax 2019 NIAID 1R44AI142939-01A1 An epitope-focused nanoparticle vaccine for anthrax WHITACRE, DAVID VLP BIOTECH, INC. CA $300,000
Anthrax 2019 NIAID 1R03AI146151-01 Defining the attachment of collagen-like protein BclA to B. anthracis spores TURNBOUGH, CHARLES UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $74,250
Anthrax 2019 NIAID 1R21AI146481-01 Branched Chain Amino Acid Metabolism During Anthrax MARESSO, ANTHONY BAYLOR COLLEGE OF MEDICINE TX $239,813
Anthrax 2019 NIAID 2R42AI122666-03 Infection Site Targeted Antitoxin Antibody (ISTAb) against Bacillus anthracis ADHIKARI, RAJAN INTEGRATED BIOTHERAPEUTICS, INC. MD $999,997
Anthrax 2019 NIGMS 2R15GM114787-02 Mechanistic aspects of the final step of heme b biosynthesis in Gram-positive bacteria LUKAT-RODGERS, GUDRUN NORTH DAKOTA STATE UNIVERSITY ND $435,000
Anthrax 2019 NIAID 272201400038C-P00012-9999-1 DEVELOPMENT OF ANTHRAX VACCINE FORMULATI0N LEMIALE, LAURENCE EMERGENT PRODUCT DEVELOPMENT GAITHERSBUR MD $3,844,268
Anthrax 2019 NIAID 272201200034C-P00014-9999-1 Technologies to Advance Next Generation Anthrax Vaccines YUSIBOV, VIDADI CENTER FOR EXPERMENTAL SOFTWARE ENGR MD MD $28,907
Anthrax 2019 NIAID 272201600013C-P00008-9999-16 MICROBIOLOGY AND INFECTIOUS DISEASES BIOLOGICAL RESEARCH REPOSITORY (MID BRR) STEDMAN, TIMOTHY AMERICAN TYPE CULTURE COLLECTION VA $692,854
Anthrax 2019 NIAID 272201000013I-P00007-27200004-1 Task C19: Efficacy of amoxicillin and amoxicillin/clavulanate in NHP model of anthrax CARROLL, MILES PUBLIC HEALTH ENGLAND UK $347
Anthrax 2019 NIAID 272201600045C-P00005-9999-1 VACCINE TECHNOLOGIES TO ADVANCE NEXT GENERATION ANTHRAX VACCINES TRANTER, HOWARD NIH $4,999,700
Anthrax 2019 NIAID 75N93019D00005-0-759301900131-2 Task A03: In Vitro Screening for Antibacterial Activity Against Biodefense and Emerging Infectious Disease Pathogens SLAYDEN, RICHARD COLORADO STATE UNIVERSITY CO $157,433
Anthrax 2019 NIAID 272201300022I-0-759301900132-1 VACCINE AND TREATMENT EVALUATION UNITS (VTEU): PROTOCOL DEVELOPMENT AND IMPLEMENTATION, FOR A PHASE 1 ANTHRAX VACCINE TRIAL KOTLOFF, KAREN UNIVERSITY OF MARYLAND BALTIMORE MD $159,112
Anthrax 2019 NIAID 272201000003I-P00004-27200006-2 Task C10: Enhancing Effectiveness of MVA Vector Vaccines BRUCE, MARY BATTELLE CENTERS/PUB HLTH RES & EVALUATN OH $56,492
Anthrax 2019 NIAID 272201800023C-P00001-9999-1 Development of a Therapeutic to Treat Anthrax in Humans JOHNSON, ALAN HAWAII BIOTECH, INC. HI $2,888,300
Anthrax 2019 NIAID 272201700040I-0-759301900271-1 Task A29: Evaluation of Candidate Medical Countermeasures for Inhalational Anthrax in the NZW Rabbit Model BEASELY, DAVID UNIVERSITY OF TEXAS MED BR GALVESTON TX $1,179,674
Anthrax 2019 NIAID 272201200003I-P00005-27200004-1 Task X04: Assessment of Simple Adjuvants to Enhance Anthrax Vaccines SABOURIN, CAROL BATTELLE CENTERS/PUB HLTH RES & EVALUATN OH $86,548
Anthrax 2019 NIDDK 1ZIADK075081-08 Understanding metabolism and stress conditions of recombinant microorganisms SHILOACH, JOSEPH NIH $277,846
Anthrax 2019 NIDDK 1ZIADK059701-46 Reactions And Immunochemistry Of Carbohydrates KOVAC, PAVOL NIH $1,201,120
Anthrax 2019 NIAID 1ZIAAI000929-17 Vaccines and Therapeutics for Anthrax LEPPLA, STEPHEN NIH $971,268
Anthrax 2019 NIAID 1ZIAAI001030-12 Molecular Genetics and Pathogenesis of Anthrax LEPPLA, STEPHEN NIH $485,634
Anthrax 2019 NIAID 1ZIAAI001032-12 Pathophysiological Actions of Anthrax Virulence Determinants LEPPLA, STEPHEN NIH $971,268
Anthrax 2019 NIAID 1ZIAAI000936-16 Pathogenesis, Treatment and Prevention of Emerging Infectious Diseases LANE, H. CLIFFORD NIH $264,633


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer